Clinical Trials on Hemorrhagic Fever

Total 10909 results

Centre Hospitalier de Cayenne
European Regional Development Fund

Recruiting

New Tools for Predicting Capillary Leak Shock During Dengue Fever (PrediDengue)

Children | Dengue Fever | Adults

France
Themis Bioscience GmbH
Assign Data Management and Biostatistics GmbH; Coalition for Epidemic Preparedness... and other collaborators

Completed

A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001)

Lassa Virus Infection

Belgium
National Institute of Allergy and Infectious Diseases...

Suspended

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

Ebola Virus Disease

United States
BioCryst Pharmaceuticals
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430

Ebola Virus Infection | Filovirus Infections

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

Ebola and Marburg Virus Vaccines

Ebola Virus Disease | Ebola Vaccines | Marburg Virus Disease | Marburgvirus | Ebolavirus

United States
Sanofi

Completed

Study of Febrile Illness for Dengue-Endemic Areas in Latin America

Fever | Dengue Fever

Colombia, Puerto Rico, Brazil, Mexico
University Hospital Center of Martinique
Institut National de la Santé Et de la Recherche Médicale, France; Clinique...

Recruiting

Cohort of Patients Infected by an Arbovirus (CARBO)

Fever | Dengue | Chikungunya | Zika Virus

France, French Guiana, Guadeloupe, Martinique, Réunion
Sanofi

Completed

Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in Asia

Fever | Dengue Fever

Malaysia, Thailand, Indonesia, Philippines, Vietnam
King's College Hospital NHS Trust
University Hospital Birmingham

Completed

An Observational Pilot Study of the Effects of Traumatic Haemorrhagic Shock and Resuscitation on the Microcirculation (MICROSHOCK)

Traumatic Haemorrhagic Shock

United Kingdom
Janssen Research & Development, LLC

Terminated

A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever

Dengue

Singapore
Bangabandhu Sheikh Mujib Medical University, Dhaka...
Institute of Technology Transfer and Innovation (ITTI)

Completed

Efficacy and Safety of Carica Papaya in Dengue Fever: A Randomised Clinical Trial

Dengue

Bangladesh
Takeda

Completed

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults

Dengue

United States
Takeda

Completed

Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)

Dengue Fever

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Completed

A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) (DPIV-002)

Dengue Fever

Puerto Rico
Kaohsiung Medical University Chung-Ho Memorial...
Ministry of Health and Medical Services, Solomon Islands; Ministry of Foreign... and other collaborators

Completed

Pilot Survey of Dengue Fever in Solomon Islands

Arbovirus Infections

Taiwan
Clinical Research Centre, Malaysia
University of Malaya

Completed

Factors Associated With Poor Dengue Outcomes in Malaysia

Dengue Fever

Malaysia
U.S. Army Medical Research and Development Command

Completed

Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease (DENV-1 PIV)

Dengue Fever

United States
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults

Dengue Fever

United States
Hawaii Biotech, Inc.

Completed

Study of HBV-001 D1 in Healthy Adults

Dengue Fever

United States
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults

Dengue Fever

United States
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults

Dengue Fever

United States
University of Oxford
MRC/UVRI and LSHTM Uganda Research Unit

Completed

A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults

Rift Valley Fever | RVF

Uganda
U.S. Army Medical Research and Development Command

Completed

Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine (MP-12)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)

Rift Valley Fever

United States
GlaxoSmithKline
Ministry of Health, Sri Lanka

Completed

A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia

Dengue

Sri Lanka
Takeda

Completed

Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants

Dengue Fever

Philippines, Dominican Republic, Panama
Takeda

Completed

Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore

Dengue Fever

Singapore
Takeda
Walter Reed Army Institute of Research (WRAIR)

Completed

Impact of SC vs IM Administration of DENVax (TDV) on Safety and Immunogenicity

Dengue Fever

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Completed

A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (DPIV-001)

Dengue Fever

United States
Mahidol University
Ministry of Health, Thailand

Unknown

Efficacy and Safety of Ivermectin Against Dengue Infection

Dengue Fever

Thailand
Tan Tock Seng Hospital
National University Hospital, Singapore; University of Malaya; Singapore General... and other collaborators

Completed

Adult Dengue Platelet Study (ADEPT)

Dengue Fever

Malaysia, Singapore
University of Surrey
GlaxoSmithKline; Sanofi Pasteur, a Sanofi Company; Innovative Medicines Initiative

Completed

Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines

Healthy

United Kingdom
University of Auckland, New Zealand

Completed

The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination

Vaccination

New Zealand
ANRS, Emerging Infectious Diseases
Saint-Louis Hospital, Paris, France; Hôpital Cochin; Bichat Hospital

Not yet recruiting

Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination

HIV Infections | Yellow Fever
U.S. Army Medical Research and Development Command

Recruiting

Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated (RVF)

Rift Valley Fever

United States
Takeda

Completed

Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years

Dengue Fever

Thailand
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia (CYD00082)

Dengue Fever

Colombia
Foundation for Innovative New Diagnostics, Switzerland
Aga Khan University

Completed

Evaluation Study of Dengue RDTs

Dengue Fever

Pakistan
Takeda

Completed

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults

Dengue Fever

United States
Takeda

Completed

Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue

Dengue Fever

United States
Rockefeller University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Yellow Fever Immune Response at Single Cell Resolution

Healthy

United States
University of Heidelberg Medical Center
University of Oxford; European Union

Completed

International Research Consortium on Dengue Risk Assessment, Management, and Surveillance (IDAMS)

Dengue Fever

Vietnam, Cambodia, Malaysia, Brazil, Bangladesh, El Salvador, Indonesia, Venezuela
Clinical Research Centre, Malaysia

Completed

The Clinical Epidemiology of Hospitalized Dengue Cases in Malaysia

Dengue Fever

Malaysia
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children

Dengue Fever

Thailand
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy Adults

Dengue Fever

United States
Kaohsiung Medical University Chung-Ho Memorial...

Completed

Clinical Specimens Testing Program of Dengue Antigen Detection Reagents

Dengue Fever

Taiwan
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine

Dengue Fever

United States
Emory University
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Recruiting

Human Immune Responses to Yellow Fever Vaccination

Yellow Fever

United States
University of Oxford

Completed

Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)

Rift Valley Fever

United Kingdom

Clinical Trials on Hemorrhagic Fever

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations